Drug
Ivabradine
Ivabradine: highest development phase Phase 2, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ivabradine NCT03137537 | Phase 2 | Lymphoma |
| ivabradine NCT01186783 | Phase 2 | Multiple Organ Dysfunction Syndrome |
Latest
No recent events.
Follow Ivabradine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.